Abstract
Introduction

1
Diabetes mellitus affects over 350 million people worldwide, (Whiting et al. 2011) 2 approximately one third of whom will go on to develop diabetic retinopathy (DR).
3
This ocular condition has become a leading cause of visual disability among 4 working-aged adults (Ruta et al. 2013) . One of the most important contributors to the 5 pathogenesis of DR is the accumulation of advanced glycation end products (AGEs) 6 and associated decreases in microcirculation. The most difficult types of DR to treat 7 successfully, even for experienced ophthalmologists, include proliferative DR (PDR) 8 and diabetic macular edema (DME). The visual prognosis remains poor for most 9 patients who develop these conditions, despite recent advances in medical and 10 surgical therapies (Shimura et al. 2008; Schoenberger et al. 2011) . One of these 11 recent advances, the use of anti-vascular endothelial growth factors to treat DME, is 12 affected by recurrence and significant numbers of non-responders in clinical use 13 (Virgili et al. 2014) . In order to prevent the development of PDR and DME in 14 patients with diabetes, it is essential to understand the underlying pathogenesis of 15 these conditions. Thus, it is important to find clinically useful new methods of 16 evaluating and understanding the accumulation of AGEs, as well as measuring 17 microcirculation decreases, in eyes with early DR. subjects with type 2 diabetes (Daimon et al. 1999; Yoshida et al. 2005) . It has been 1 suggested that higher plasma levels of pentosidine may contribute to increased 2 vascular rigidity of the retinal arteries in patients with type 2 diabetes and early DR 3 (Sato et al. 2012) . Furthermore, levels of skin autofluorescence (SAF), a 4 non-invasive measurement parameter that has been introduced to assess tissue AGE 5 levels, have been reported to be associated with various diabetes-related 6 abnormalities and complications (Lutgers et al. 2009 ). Previously, biomarkers of 7 systemic oxidative stress, such as SAF and serum pentosidine levels, have been 8 reported to be associated with renal and cardiovascular diseases (Sugiyama et al. 9 1998; Lutgers et al. 2006; Koyama et al. 2007; Meerwaldt et al. 2007 ; Koyama et al. (NPDR) (Hirano et al. 2014; Yasuda et al. 2015) .
14
The introduction of laser speckle flowgraphy (LSFG) and its most important 15 measurement parameter, mean blur rate (MBR, an index of ocular blood flow), has 16 made it easy to measure ocular microcirculation (Konishi et al. 2002; Watanabe et al. 17 2015). Recently, it was reported that peripheral hemodynamics were negatively 1 correlated with oxidative stress in healthy subjects, as well as in those with chronic 2 heart failure (Nozawa et al. 2008; Inoue et al. 2012) . In this study, we determined 3 whether ocular microcirculation was associated with AGEs, an oxidative stress 4 marker, as well as with other clinical findings, including CMT, in type 2 diabetes 5 patients with early DR. 
Materials and Methods
8
SETTING AND DESIGN
9
This was an institutional, cross-sectional study. 
PATIENTS
12
The subjects included in this study comprised NDR or NPDR patients with type 2 13 diabetes, all of whom were observed at Tohoku University Hospital. All patients 14 underwent a baseline ophthalmic examination, including measurement of visual macular degeneration, glaucoma, or retinal diseases other than NPDR. 
MEASUREMENT OF PHYSICAL AND OPHTHALMOLOGICAL FINDINGS
9
Systolic blood pressure and diastolic blood pressure (SBP and DBP) were measured 10 after the patients had rested in a sitting position for 10 min. Measurements were 11 made in the left brachial artery at the height of the heart by an automated blood 12 pressure monitor (HEM-759E, Omron Corporation, Kyoto, Japan). LSFG was then 13 used to measure optic nerve head (ONH) circulation. The subjects did not fast before this study, as in our previous report, care was taken to measure SAF at the same 4 location, the inner forearm, in each patient (Yasuda et al. 2015) . Before the LSFG measurement, the pupils of each subject were dilated with 0.5% 8 tropicamide and 0.5% phenylephrine hydrochloride. The details of the underlying 9 principles of LSFG (Softcare, Fukutsu, Japan) have been described in previous 10 reports ( Tamaki et al. 1995; Isono et al. 2003 
Results
4
The clinical characteristics of both the diabetes patients and the non-diabetic controls 5 are shown in Table 1 . This study included 46 patients with type 2 diabetes, with a 6 median age of 53 years (IQR 39-61).
7
A single regression analysis revealed that SAF in the diabetes patients was 
21
Separate multiple regression analyses of independent contributing factors revealed 22 that age, SAF, pentosidine concentration, duration of diabetes and pulse rate 23 contributed to tissue MBR (P = 0.041, P = 0.046, P = 0.022, P = 0.011 and P = 0.036, respectively, Table 2 ), and SAF, HbA1c, pulse rate, tissue MBR, diastolic blood 1 pressure and creatinine concentration contributed to CMT (P = 0.005, P = 0.039, P < 2 0.001, P < 0.001, P = 0.022 and P = 0.001, respectively, Table 3 
16
Although it is suspected that the accumulation of AGEs is associated with poor 17 control of diabetes and renal failure, a direct relationship has not been established,
18
nor has a definitive relationship been established between AGEs and age. However,
19
SAF has been found to be relatively high in patients with type 2 diabetes, having a 20 median value of more than 2.0 AU (Tanaka et al. 2012 ). This finding was confirmed 21 in our current data. Our data also supported previous observations that age is . 1998 ). This discrepancy might have arisen because of differences in the 6 distribution of patients between this and previous studies: our study specifically 7 selected subjects with NDR or NPDR, and accordingly included only a small number 8 of patients with renal insufficiency (only 5 of 46 patients had a creatinine level more 9 than 1.0 mg/dl, and none had a level more than 2.0 mg/dl). By contrast, the earlier 10 study had a high rate of PDR combined with renal insufficiency (Sugiyama et al.
11
1998).
12
Among biomarkers of systemic oxidative stress, SAF and serum pentosidine have 13 both been reported to reflect AGE levels. Nevertheless, the direct relationship 14 between these two measurement parameters remains unclear. As these measurements we consider it likely that systemic measurements of serum pentosidine do not 10 directly reflect local measurements of AGEs in the skin, and that serum pentosidine 11 measurements should thus be interpreted separately from measurements of AGEs in 12 the skin, even in early DR.
13
The most interesting finding of the current study was the negative correlation of 14 AGE markers, particularly serum pentosidine, with ONH blood flow in NPDR eyes.
15
This is understandable, despite the inclusion in our study of only NDR or NPDR 16 patients, because serum levels of AGEs have previously been reported to be related 17 to diabetic complications, including DR (Ono et al. 1998; Ono et al. 1998) . AGE In contrast to serum pentosidine, we found that HbA1c was not correlated with thought to be one of the most important causes of DME, but a recent report showed 5 that neither SAF, HbA1c or self-assessed DM duration correlated with DME 6 prevalence or severity (Hirano et al. 2014 ). In our previous work on ocular blood 7 flow in DME, we found that MBR in the ONH was negatively correlated with CMT 8 after the intravitreal administration of bevacizumab (r = -0.80) (Nitta et al. 2014 ).
9
While there were no clinically significant DME patients in our current study, we Our study was limited by its cross-sectional design, its small sample size, and the 10 lack of healthy control subjects. 
